Change Healthcare
Market Cap
US$1.7b
Last Updated
2019/09/17 01:00 UTC
Data Sources
Company Financials +
Executive Summary
Change Healthcare Inc., an independent healthcare technology platform, provides data and analytics-driven solutions to improve clinical, financial, and patient engagement outcomes in the United States healthcare system.
Snowflake
Fundamentals
Adequate balance sheet with reasonable growth potential.
Similar Companies
Share Price & News
How has Change Healthcare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
19.0%
NasdaqGS:CHNG
2.1%
US Healthcare Services
1.1%
US Market
1 Year Return
n/a
NasdaqGS:CHNG
7.7%
US Healthcare Services
2.1%
US Market
No trading data on CHNG.
No trading data on CHNG.
Share holder returns
| CHNG | Industry | Market | |
|---|---|---|---|
| 7 Day | 19.0% | 2.1% | 1.1% |
| 30 Day | -7.1% | -4.7% | 3.7% |
| 90 Day | n/a | -4.6% | 2.3% |
| 1 Year | n/a | 7.7%7.7% | 4.4%2.1% |
| 3 Year | n/a | 51.1%50.8% | 47.0%37.4% |
| 5 Year | n/a | 49.2%48.3% | 61.6%43.8% |
Price Volatility Vs. Market
How volatile is Change Healthcare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is Change Healthcare undervalued based on future cash flows and its price relative to the stock market?
>50%
Discount to future cash flow value
Intrinsic Value Based on Future Cash Flows
Change Healthcare's share price is below the future cash flow value, and at a moderate discount (> 20%).
Change Healthcare's share price is below the future cash flow value, and at a substantial discount (> 40%).
Price Based on Earnings
Change Healthcare is loss making, we can't compare its value to the US Healthcare Services industry average.
Change Healthcare is loss making, we can't compare the value of its earnings to the United States of America market.
Price Based on Expected Growth
Unable to calculate PEG ratio for Change Healthcare, we can't assess if its growth is good value.
Price Based on Value of Assets
Change Healthcare is good value based on assets compared to the US Healthcare Services industry average.
Next Steps
Future Growth
How is Change Healthcare expected to perform in the next 1 to 3 years based on estimates from 13 analysts?
30.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
Unable to determine if Change Healthcare is high growth as no revenue estimate data is available.
Change Healthcare's earnings are expected to grow significantly at over 20% yearly.
Unable to compare Change Healthcare's revenue growth to the United States of America market average as no estimate data is available.
Change Healthcare's earnings growth is expected to exceed the United States of America market average.
Change Healthcare's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Earnings per Share Growth Estimates
Future Return on Equity
Change Healthcare is expected to make outstanding use of shareholders’ funds in the future (Return on Equity greater than 40%).
Next Steps
Past Performance
How has Change Healthcare performed over the past 5 years?
-208.2%
Last years earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Change Healthcare does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
Unable to compare Change Healthcare's 1-year earnings growth to the 5-year average as it is not currently profitable.
Unable to compare Change Healthcare's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.
Return on Equity
It is difficult to establish if Change Healthcare has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
Return on Assets
It is difficult to establish if Change Healthcare has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.
Return on Capital Employed
It is difficult to establish if Change Healthcare improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
Next Steps
Financial Health
How is Change Healthcare's financial position?
Financial Position Analysis
Change Healthcare's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
Change Healthcare's long term commitments exceed its cash and other short term assets.
Debt to Equity History and Analysis
Change Healthcare has no debt.
Change Healthcare has not taken on any debt in the past 5 years.
Balance Sheet
Low level of unsold assets.
Change Healthcare has no debt, it does not need to be covered by short term assets.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Whilst loss making Change Healthcare has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
Whilst loss making Change Healthcare has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -99% per year.
Next Steps
Dividend
What is Change Healthcare's current dividend yield, its reliability and sustainability?
Dividend Yield and Payments Analysis
Unable to evaluate Change Healthcare's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Change Healthcare's dividend against the top 25% market benchmark as the company has not reported any payouts.
Unable to perform a dividend volatility check as Change Healthcare has not reported any payouts.
Unable to verify if Change Healthcare's dividend has been increasing as the company has not reported any payouts.
Current Payout to Shareholders
Unable to calculate sustainability of dividends as Change Healthcare has not reported any payouts.
Future Payout to Shareholders
No need to calculate the sustainability of Change Healthcare's dividends in 3 years as they are not expected to pay a notable one for United States of America.
Next Steps
Management
What is the CEO of Change Healthcare's salary, the management and board of directors tenure and is there insider trading?
0.3yrs
Average board tenure
CEO
Neil de Crescenzo (58yo)
0yrs
Tenure
US$2,435,910
Compensation
Mr. Neil E. de Crescenzo, IV serves as President and Chief Executive Officer at Change Healthcare, Inc. Mr. de Crescenzo has been a Director of Change Healthcare Inc. since June 26, 2019. He has been the C ...
CEO Compensation Analysis
Neil's remuneration is lower than average for companies of similar size in United States of America.
Neil's compensation has been consistent with company performance over the past year, both up more than 20%.
Board Age and Tenure
0.3yrs
Average Tenure
58yo
Average Age
The average tenure for the Change Healthcare board of directors is less than 3 years, this suggests a new board.
Insider Trading
More shares have been bought than sold by Change Healthcare individual insiders in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Chief Executive Officer President |
| Shares | 75,000 |
| Max Price | US$14.17 |
| Entity | Individual |
| Role | Chief Financial Officer Executive VP & CFO |
| Shares | 40,000 |
| Max Price | US$13.73 |
| Entity | Individual |
| Role | Member of the Board of Directors Director |
| Shares | 5,000 |
| Max Price | US$13.00 |
| Entity | Individual |
| Role | Senior Key Executive EVP & President of Software and Analytics |
| Shares | 2,000 |
| Max Price | US$13.00 |
| Entity | Individual |
| Role | Chief Financial Officer Executive VP & CFO |
| Shares | 30,000 |
| Max Price | US$13.00 |
| Entity | Individual |
| Role | Head of Marketing Executive VP & Chief Marketing Officer |
| Shares | 1,000 |
| Max Price | US$13.00 |
| Entity | Individual |
| Role | Chief Operating Officer Executive VP and President of Sales & Operations |
| Shares | 1,000 |
| Max Price | US$13.00 |
Ownership Breakdown
Management Team
Neil de Crescenzo (58yo)
President
- Tenure: 0yrs
- Compensation: US$2.44m
Alex Choy (57yo)
Executive VP of Research & Development
- Tenure: 0yrs
- Compensation: US$2.98m
Fredrik Eliasson (48yo)
Executive VP & CFO
- Tenure: 1.5yrs
- Compensation: US$7.84m
Thomas McEnery (57yo)
Executive VP & Chief Marketing Officer
- Tenure: 0yrs
Rod O’Reilly (57yo)
EVP & President of Software and Analytics
- Tenure: 0yrs
- Compensation: US$3.07m
Linda Whitley-Taylor (55yo)
Chief People Officer & Executive VP
- Tenure: 0yrs
August Calhoun (47yo)
Executive VP and President of Sales & Operations
- Tenure: 0yrs
- Compensation: US$2.65m
Evan Smith
Senior Vice President of Investor Relations
- Tenure: 0yrs
Thomas Laur (44yo)
Executive VP & President of Technology Enabled Services
- Tenure: 0yrs
- Compensation: US$4.00m
Loretta Cecil (61yo)
Executive VP & General Counsel
- Tenure: 0yrs
Board Members
Neil Simpkins (53yo)
Director
- Tenure: 0.3yrs
Philip Pead (66yo)
Director
- Tenure: 0.3yrs
- Compensation: US$197.76k
Neil de Crescenzo (58yo)
President
- Tenure: 0yrs
- Compensation: US$2.44m
Bob Zollars (62yo)
Director
- Tenure: 0.3yrs
- Compensation: US$182.76k
John Hammergren (60yo)
Chairman of the Board
- Tenure: 0.2yrs
Howard Lance (63yo)
Director
- Tenure: 0.3yrs
- Compensation: US$209.70k
Phil Roe (58yo)
Director
- Tenure: 0.3yrs
- Compensation: US$197.76k
Bansi Nagji (54yo)
Director
- Tenure: 0.3yrs
Nick Kuhar (33yo)
Director
- Tenure: 0.3yrs
Britt Vitalone (50yo)
Director
- Tenure: 0.3yrs
Company Information
Change Healthcare Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Change Healthcare Inc.
- Ticker: CHNG
- Exchange: NasdaqGS
- Founded: 2016
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: US$1.709b
- Shares outstanding: 124.85m
- Website: https://www.changehealthcare.com
Location
- Change Healthcare Inc.
- 3055 Lebanon Pike
- Suite 1000
- Nashville
- Tennessee
- 37214
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CHNG | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Jun 2019 |
| 1CB | MUN (Boerse Muenchen) | Yes | Common Stock | DE | EUR | Jun 2019 |
Biography
Change Healthcare Inc., an independent healthcare technology platform, provides data and analytics-driven solutions to improve clinical, financial, and patient engagement outcomes in the United States heal ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/09/17 01:00 |
| End of Day Share Price | 2019/09/16 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2019/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.